FGF4, fibroblast growth factor 4, 2249

N. diseases: 86; N. variants: 0
Disease: Carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.060 AlteredExpression group BEFREE Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors. 8010723 1994
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.060 Biomarker group BEFREE The telomeric one includes the D11S146/BCL1/INT2/HST area and is relevant to DNA amplification in carcinomas and to B-cell translocations. 2071147 1991
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.060 AlteredExpression group BEFREE HST-1 and INT-2 genes which is a member of fibroblast growth factor gene family, are amplified in approximately 50% of primary tumors and all the metastatic tumors of esophageal carcinomas. 2098274 1990
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.060 GeneticVariation group BEFREE Concerning band q13: (i) 50 tumors (approximately 17%) were co-amplified for BCL-1, HST & INT-2; (ii) in 3 cases, amplification extended to the SEA gene; (iii) in 6 carcinomas, BCL-1 was the only amplified marker. 2181375 1990
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.060 GeneticVariation group BEFREE No coamplification of the hst-1 and int-2 genes was detected in gastric carcinomas and colorectal carcinomas. 2529025 1989
CUI: C0007097
Disease: Carcinoma
Carcinoma 		0.060 AlteredExpression group BEFREE Amplification of the hst-1 gene in human esophageal carcinomas. 3136110 1988